Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.97)
# 90
Out of 5,128 analysts
627
Total ratings
53.1%
Success rate
33.2%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Reiterated: Buy | $56 | $28.30 | +97.88% | 47 | Nov 11, 2026 | |
| DCTH Delcath Systems | Reiterated: Buy | $24 → $27 | $21.38 | +26.29% | 29 | Nov 10, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Hold | $1.25 | $0.6301 | +98.38% | 32 | Nov 6, 2026 | |
| ETON Eton Pharmaceuticals | Reiterated: Buy | $76 → $82 | $61.45 | +33.44% | 40 | Nov 6, 2026 | |
| IRWD Ironwood Pharmaceuticals | Reiterated: Buy | $6 | $4.85 | +23.71% | 34 | Nov 6, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $12 → $18 | $16.65 | +8.11% | 32 | Nov 6, 2026 | |
| BVS Bioventus | Reiterated: Buy | $18 → $16 | $10.86 | +47.33% | 29 | Nov 3, 2026 | |
| CELC Celcuity | Reiterated: Buy | $173 → $151 | $64.17 | +135.31% | 30 | Nov 2, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $7 | $3.24 | +116.05% | 47 | Oct 29, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $20 → $15 | $6.23 | +140.77% | 36 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $5 | $0.8121 | +515.69% | 4 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.75 | - | 14 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2 | $0.86 | +132.56% | 1 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.97 | - | 16 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.20 | - | 1 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.67 | +49.93% | 25 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.81 | +120.99% | 20 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $8.56 | +98.60% | 5 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 | $10.90 | +65.14% | 34 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $0.6 | $0.2753 | +117.94% | 38 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.69 | +62.60% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.1 → $1.7 | $1.21 | +40.50% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $6.40 | +87.50% | 19 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.40 | - | 1 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.24 | - | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.33 | - | 24 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $55.45 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $119.44 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $58.96 | n/a | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $24.45 | n/a | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $316.27 | n/a | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.29 | n/a | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.43 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.04 | n/a | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.21 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $11.15 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.59 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $34.95 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $13.94 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $9.28 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.95 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.65 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $0.6965 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $17.19 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $14.79 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $29.11 | n/a | 1 | May 3, 2023 |
Harrow
Nov 11, 2026
Reiterated: Buy
Price Target: $56
Current: $28.30
Upside: +97.88%
Delcath Systems
Nov 10, 2026
Reiterated: Buy
Price Target: $24 → $27
Current: $21.38
Upside: +26.29%
CVRx, Inc.
Nov 6, 2026
Reiterated: Hold
Price Target: $1.25
Current: $0.6301
Upside: +98.38%
Eton Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $76 → $82
Current: $61.45
Upside: +33.44%
Ironwood Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $6
Current: $4.85
Upside: +23.71%
Xeris Biopharma Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $12 → $18
Current: $16.65
Upside: +8.11%
Bioventus
Nov 3, 2026
Reiterated: Buy
Price Target: $18 → $16
Current: $10.86
Upside: +47.33%
Celcuity
Nov 2, 2026
Reiterated: Buy
Price Target: $173 → $151
Current: $64.17
Upside: +135.31%
MiMedx Group
Oct 29, 2026
Reiterated: Buy
Price Target: $7
Current: $3.24
Upside: +116.05%
Phathom Pharmaceuticals
Oct 21, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $6.23
Upside: +140.77%
Oct 19, 2026
Reiterated: Buy
Price Target: $48 → $5
Current: $0.8121
Upside: +515.69%
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.75
Upside: -
Sep 25, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.86
Upside: +132.56%
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.97
Upside: -
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.20
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: $10
Current: $6.67
Upside: +49.93%
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $1.81
Upside: +120.99%
Aug 14, 2026
Reiterated: Buy
Price Target: $17
Current: $8.56
Upside: +98.60%
Aug 12, 2026
Rated: Buy
Price Target: $18
Current: $10.90
Upside: +65.14%
Aug 12, 2026
Rated: Buy
Price Target: $0.6
Current: $0.2753
Upside: +117.94%
Aug 6, 2026
Reiterated: Buy
Price Target: $6
Current: $3.69
Upside: +62.60%
Aug 6, 2026
Reiterated: Buy
Price Target: $1.1 → $1.7
Current: $1.21
Upside: +40.50%
Jul 22, 2026
Reiterated: Buy
Price Target: $12
Current: $6.40
Upside: +87.50%
Jul 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.40
Upside: -
Jun 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.24
Upside: -
Jun 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.33
Upside: -
Nov 20, 2025
Reiterated: Buy
Price Target: n/a
Current: $55.45
Upside: -
Nov 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $119.44
Upside: -
Oct 20, 2025
Reiterated: Buy
Price Target: n/a
Current: $58.96
Upside: n/a
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $24.45
Upside: n/a
Oct 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $316.27
Upside: n/a
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $36.29
Upside: n/a
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $1.43
Upside: n/a
Jul 22, 2025
Reiterated: Buy
Price Target: n/a
Current: $61.04
Upside: n/a
Jul 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $10.21
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $12
Current: $11.15
Upside: n/a
Feb 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.59
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $34.95
Upside: n/a
Aug 1, 2024
Reiterated: Buy
Price Target: $38
Current: $13.94
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $9.28
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $10
Current: $4.95
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $4.65
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $0.6965
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $17.19
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $14.79
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $29.11
Upside: n/a